News

This study of Medicaid records from 29,193 women found that pregnant women who received OUD treatment, including medication, talk-based therapies, or both, had significantly better pregnancy outcomes than those who received no treatment.

SAMHSA has issued a new case study guide. This publication summarizes information about the postpartum period, presents an innovative program as a case study, and offers practical advice for care teams on comprehensive, collaborative perinatal care.

The updated regulations promote increased access to evidence-based medications for opioid use disorder, greater retention in care by promoting practitioner’s professional judgment in providing patient-centered care and reducing barriers to services.

Wednesday, June 3, 2-3:30 p.m. ET
SAMHSA’s Office of the Chief Medical Officer will host this webinar. The webinar will explore a range of psychiatric treatment options and strategies to support fully informed care, including understanding benefits, potential risks, dependence, and withdrawal considerations.

SAMHSA has issued a new advisory. This advisory is intended for healthcare providers, including pediatricians, adolescent medicine specialists, primary care providers, and geriatricians.

Thursday, May 14, 1-2 p.m. ET
SAMHSA’s Center for Financing Reform and Innovation (CFRI) is releasing a report and hosting a webinar titled Revised Regulations for Opioid Treatment Programs: Establishing a Baseline to Measure Progress Over Time.